Abstract:Objective To analyze the clinical characteristics,survival,and prognosis of the patients with different molecular subtypes of breast cancer.Methods Clinical data of 304 patients with histopathologically confirmed resectable breast cancer,treated in the 1st Affiliated Hospital of Kunming Medical University from Feb.2002 to Feb.2004,were collected and analyzed in this study.ER,PR and HER-2 in all the excised tissues were determined by immunohistochemistry,and according to the results,the patients were divided into luminal,HER-2 and triple-negative breast cancer.The clinical characteristics,recurrence and survival of the patients with different subtypes of breast cancer were analyzed.Results In this study,luminal,HER-2 and triple-negative breast cancer accounted for 53.0%,20.4% and 26.6%,and the median age of patients with the three subtypes was 50.8,50.3and 47.1,respectively.Histological grade of luminal type was lower than other subgroup of breast cancer.The percentage of luminal type with histological grade I was 43.1%.HER-2 type was commonly seen in premenopausal women(66.1%),its histological grade was between luminal and triple-negative type.Triple-negative breast cancer was more likely to be found in younger patients frequently with a familial history of breast cancer(9.9%).Histological grade of triple-negative breast cancer was higher than other groups.The percentage of triple-negative patients with histological grade III was 49.0%.Among the three type patients,there was no significant difference in menopausal status,tumor stage,pathologic types and lymph node metastasis.By Feb.2009,the median time of follow-up was 71 months(60～84 months).Patients with HER-2 or triple-negative breast cancer were found to have a significantly higher recurrence and metastasis rate than the patients with luminal type breast cancer,but no significant difference was observed between triple-negative and HER-2 types.HER-2 type patients were more likely to develop bone metastases than triple-negative patients(46.7% vs 13.3%,P0.05),and triple-negative patients were more likely to develop lung metastases than HER-2 patients(46.7% vs 20.3%,P0.05).Up to February 2009,the 5-year disease-free rates(DFS)for patients with Luminal,HER-2 and triple-negative types were 90.1%,75.8% and 76.5%(P0.05),respectively.The overall 5-year survival rates(OS)of the three groups were 96.9%,85.5% and 87.7%(P0.05),respectively.Conclusion Patients with different subtype of breast cancer have different clinical characteristics,recurrence pattern and prognosis.

Relationship of Clinicopathological Features and Prognosis of Breast Cancer with Different Molecular Subtypes in the Elderly

The clinical features of breast cancer in young patients

A Study on the Relationship Between Breast Cancer Molecular Classification and Prognosis

Pathological features and prognosis of different molecular subtypes of breast cancer

Clinical Characteristics and Prognosis of Different Subtypes of Breast Cancer

The Prognostic Impact of Age in Different Molecular Subtypes of Breast Cancer: a Population-Based Study.

Characteristics and prognosis for molecular breast cancer subtypes in Chinese women

Association Between Hormone Receptors And Her-2/Neu Is Age-Related

Metastasis patterns and prognosis of octogenarians with metastatic breast cancer: A large-cohort retrospective study

Clinical and Pathological Characteristics and Treatment of Elderly Patients with Breast Cancer

[Relationship Between Breast Cancer Molecular Subtypes with Clinicopathological Characteristics and Prognosis].

[Clinical Features and Prognosis in Breast Cancer Patients over 70 Years of Age].

Clinicopathological Features and Treatment Sensitivity of Elderly Chinese Breast Cancer Patients.

Clinicopathological Features, Treatment and Prognosis of Invasive Breast Cancer Patients over 70 Years Old

Clinicopathological Features and Prognosis of Triple-Negative Breast Cancer: a Comparison Between Younger (<60) and Elderly (≥60) Patients.

Molecular Subtype Approximated by Quantitative Estrogen Receptor, Progesterone Receptor and Her2 Can Predict the Prognosis of Breast Cancer

Clinical Characteristics of Different Molecular Subtypes of Breast Cancer in Young Patients

Clinical significance of four subtypes of breast cancer

Molecular classification of geriatric breast cancer displays distinct senescent subgroups of prognostic significance

Correlation Study Between Advanced Age and Inferior Prognosis in Stage Ⅱ Colorectal Cancer Patients

Letter: HL-A and disease. Registration of available data.